IO Biotech

IO Biotech

Biotechnology
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

$112M

Market Cap • 7/15/2025

2021

(4 years)

Founded

2021

(4 years ago)

IPO

NASDAQ

Listing Exchange

Flag of DK

Copenhagen N

Headquarters